Burkett Financial Services’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$696K Sell
2,740
-68
-2% -$15.8K 0.22% 33
2026
Q1
$686K Sell
2,808
-85
-3% -$19.8K 0.24% 32
2025
Q4
$599K Buy
2,893
+17
+0.6% +$3.36K 0.2% 35
2025
Q3
$533K Sell
2,876
-197
-6% -$33.8K 0.18% 37
2025
Q2
$469K Sell
3,073
-28
-0.9% -$4.3K 0.17% 36
2025
Q1
$514K Sell
3,101
-81
-3% -$12.7K 0.21% 34
2024
Q4
$460K Sell
3,182
-512
-14% -$79.3K 0.19% 35
2024
Q3
$599K Sell
3,694
-118
-3% -$18.8K 0.25% 31
2024
Q2
$557K Buy
3,812
+31
+0.8% +$4.61K 0.29% 29
2024
Q1
$598K Sell
3,781
-122
-3% -$19.4K 0.31% 29
2023
Q4
$612K Buy
+3,903
New +$598K 0.34% 27

Other funds holding JNJ

Burkett Financial Services's JNJ Position: Q2 2026 in Review

Burkett Financial Services reduced its Johnson & Johnson (JNJ) stake by 2.4% in Q2 2026, selling an estimated $15.8K and leaving 2,740 shares worth $696K. The position accounts for 0.22% of the portfolio, ranked #33.

Burkett Financial Services first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Burkett Financial Services held 2,740 shares of Johnson & Johnson worth $696K as of Q2 2026.
  • Burkett Financial Services sold 68 Johnson & Johnson shares in Q2 2026, an estimated $15.8K.
  • Johnson & Johnson made up 0.22% of Burkett Financial Services's portfolio in Q2 2026, its #33 holding.
  • Burkett Financial Services first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Burkett Financial Services's 13F filing for Q2 2026, filed 2 Jul 2026.